Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO

Clinical trial NCT02006147 · COMPLETED

Trial details

NCT number: NCT02006147
Sponsor: Taiwan Liposome Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Central Retinal Vein Occlusion With Macular Edema Branch Retinal Vein Occlusion With Macular Edema

Start date: 2014-11-01
Primary completion: 2020-07-15
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.